Accessibility StatementSkip Navigation LONDON, Sept. 8, 2025 /PRNewswire/ -- Brightstar Lottery PLC (NYSE: BRSL) ("Brightstar") announced today that it will demonstrate its impressive portfolio of world-class lottery solutions at the 12 EL Congress, presented by European Lotteries, from Sept. 14-17 in Bern, Switzerland. "The EL Congress provides a compelling opportunity for Brightstar to introduce our new brand to our partners in Europe and reinforce our commitment to being a pure-play lottery business, foc ...

Sep 8, 2025 6:45 AM Eastern Daylight Time Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula Share NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, "Pfizer†) and BioNTech SE (Nasdaq: BNTX, "BioNTech†) today announced positive topline results from an ongoing Phase 3 clinical trial cohort evaluating the safety, tolerability, and immunogenicity of a 30-µg dose of the LP.8.1-adapted monovalent COMIRNA ...

SYRACUSE, N.Y.--(BUSINESS WIRE)--Community Financial System, Inc. Announces Investment in Leap Holdings, Inc. ...

Revenue grew 26% year-over-year, and 49% in constant currency in H1 2025 over H1 2024 Achieved Net Income of $0.43 million in H1 2025 The share of dollar-pegged revenue in our portfolio increased from 18% in H1 2024 to 34% in H1 2025, with recurring revenue reaching 85% of total revenue and Net Dollar Retention of 118% DUBAI, United Arab Emirates, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a global provider of transformative tech-enabled mass transit sol ...

Accessibility StatementSkip Navigation In the Phase 3 BRUIN CLL-313 study, treatment with pirtobrutinib demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival versus bendamustine plus rituximab, indicating one of the most compelling effect sizes ever observed for a single agent BTK inhibitor in a front-line CLL study BRUIN CLL-313 is the third positive Phase 3 study from the pirtobrutinib development program in CLL Results from BRUIN CLL-313 and B ...

Accessibility StatementSkip Navigation LUXEMBOURG, September 8, 2025 /PRNewswire/ -- Adecoagro S.A. (NYSE: AGRO) ("Adecoagro" or the "Company"), a leading sustainable production company in South America announces it has signed an agreement to acquire Nutrien Ltd.'s 50% interest in Profertil S.A. ("Profertil"), the largest producer of granular urea in South America. The remaining 50% stake of Profertil is owned by YPF S.A. the largest oil and gas producer of Argentina. Adecoagro will execute this acquisition ...

LONDON and ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that U.K.-based customs consultancy Customs Assured is streamlining and automating large portions of the customs documentation process for its clients by using Descartes e-Customs™. Enhanced by artificial intelligence (AI) from AiDock, the combined solution reduces the time spent on repetitive manual tasks associated with c ...

截至发稿，久立特材市值为222亿元。 每经头条（nbdtoutiao）——"中国真正实现了弯道超车"！从美国回来14年，陈智胜亲历中国创新药大 爆发：以前跨国药企不太信任中国数据，但现在不同了 （记者 曾健辉） 每经AI快讯，久立特材（SZ 002318，收盘价：22.74元）9月8日晚间发布公告称，浙江久立特材科技股 份有限公司于2025年9月5日收到公司实际控制人周志江先生的通知，其通过100%持股的湖州一亩田企 业管理有限公司在二级市场增持公司股份1,200,000股，占公司总股本的0.12%，交易总金额为 26,369,484.92元。 2025年1至6月份，久立特材的营业收入构成为：石油和化工和天然气占比61.36%，电力设备制造占比 15.18%，其他机械制造占比13.5%，其他不可分行业占比9.96%。 ...

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that it has entered into an agreement to sell its 50 percent equity position in Argentina-based nitrogen producer Profertil S.A. (Profertil) to Adecoagro S.A. and Asociacion de Cooperativas Argentinas Coop Ltda through a joint acquisition. The purchase price for Nutrien's shares in Profertil is expected to be approximately US$600 million on a pre-tax basis. "The agreement to sell our equity stake in Profe. ...

9月8日，软控股份通过电话会议形式接受了中信建投、华泰资产、天风证券、嘉实基金、财通证券、施 罗德投资等6家机构的调研。公司证券部及子公司领导接待了来访机构，就锂电业务布局、产品、竞争 优势、固态电池布局、客户结构及毛利率等方面进行了交流。 锂电业务布局与产品 浙江软控智能科技股份有限公司作为软控子公司，为锂电池等生产制造商提供物料自动化处理整体解决 方案，助力客户向数字化、柔性化、智能化转型升级。其主要产品为定制化的物料自动化处理智能产线 和设备，形成了以"智能设备-物料处理系统-智能软件-智能产线"为支撑的整线产业布局。自主研发四大 产品系统，物料自动化产线和单机设备可满足多项或单项物料处理工艺需求。同时，基于前端配料、匀 浆工序优势，产品已扩展至涂布机等锂电前段核心设备，覆盖锂电池极片制片全环节。 竞争优势与固态电池布局 经过多年发展，软控股份凭借完备的核心技术储备和行业应用经验，能为锂电池行业客户提供定制化解 决方案，产品获宁德时代等下游龙头认可，已成为主要供应商之一。公司持续研发投入，在电池领域物 料自动化处理重要环节拥有核心技术，通过专利转化形成众多核心设备和产品。 客户结构与毛利率分析 公司锂电 ...